|
|
.
See Category: Endocrine, nutritional and metabolic diseases
See Header: Other amyloidosis
ICD-10 (CM) Code and Descriptor
|
E85.82 |
Wild-type transthyretin-related (ATTR) amyloidosis
|
E8582 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 40.55%
|
17.97%
|
12.35%
|
8.59%
|
5.67%
|
4.01%
|
3.25%
|
2.07%
|
1.49%
|
1.16%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for E85.82*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,191
|
1,194
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
681
|
684
|
|
83880
|
ASSAY OF NATRIURETIC PEPTIDE |
623
|
626
|
|
80053
|
COMPREHEN METABOLIC PANEL |
510
|
510
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
388
|
388
|
|
84484
|
ASSAY OF TROPONIN QUANT |
378
|
382
|
|
80048
|
METABOLIC PANEL TOTAL CA |
337
|
337
|
|
J0222
|
INJ., PATISIRAN, 0.1 MG |
288
|
53,883
|
|
93005
|
ELECTROCARDIOGRAM TRACING |
278
|
280
|
|
84134
|
ASSAY OF PREALBUMIN |
267
|
267
|
|
83735
|
ASSAY OF MAGNESIUM |
241
|
242
|
|
96365
|
THER/PROPH/DIAG IV INF INIT |
204
|
205
|
|
93306
|
TTE W/DOPPLER COMPLETE |
201
|
201
|
|
A9538
|
TC99M PYROPHOSPHATE |
164
|
172
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
162
|
1,468
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
161
|
389
|
|
82784
|
ASSAY IGA/IGD/IGG/IGM EACH |
146
|
286
|
|
85027
|
COMPLETE CBC AUTOMATED |
144
|
144
|
|
84165
|
PROTEIN E-PHORESIS SERUM |
134
|
134
|
|
83883
|
ASSAY NEPHELOMETRY NOT SPEC |
133
|
199
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
E85.82 related to the following DRG Codes:
545-547
|
